Journals / İstanbul Medical Journal / 2018 / Cilt: 19 - Sayı: 3

Eosinophilic Pulmonary Diseases in Adults

Erişkinlerde Eozinofilik Akciğer Hastalıkları

Pages
189–193
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article primary eosinophylic pulmonary diseases are reviewed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Eosinophilic pulmonary disease in adults are characterised with pulmonary infitrates associated with peripheral eosinophilia >250/ microliter.
📊
Key Findings & Data:Sometimes peripheric eosinophilia may be absent and eosinophils may be increased in airways and pulmonary paranchima, leading to altered mediators and tissue damage.
💡
Conclusion & Impact:In this article primary eosinophylic pulmonary diseases are reviewed.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Eosinophilic pulmonary disease in adults are characterised with pulmonary infitrates associated with peripheral eosinophilia >250/ microliter. Sometimes peripheric eosinophilia may be absent and eosinophils may be increased in airways and pulmonary paranchima, leading to altered mediators and tissue damage. Clinical presentation includes pulmonary and constitional symptoms. The most wellknown pulmonary eosinophylic diseases are parasitic infestations, drug reactions, acute and chronic eosinophylic pneumonia, bronchopulmonary aspergillosis and Churg-Strauss Syndrome. In this article primary eosinophylic pulmonary diseases are reviewed.

Özet

Erişkinlerde akciğerlerde infiltrasyon ile birlikte periferik kandamutlak eozinofil sayısının 250/mikrolitrenin üzerinde bulunması ilekarakterize olan eozinofilik akciğer hastalıkları periferde eozinofiliolmaksızın yalnız solunum yolları ve/veya parenkimde eozinofillerinartması ve buna bağlı mediatörlerin yaptığı doku hasarı ile seyreder.Klinikte solunum sistemine ait belirtiler ve konstitisyonel semptomlarvardır. En bilinen eozinofilik akciğer hastalıkları parazit enfestasyonları,ilaç reaksiyonları, akut ve kronik eozinofilik pnömoniler, hipereozinofiliksendrom, bronkopulmoner aspergilloz, Churg-StraussSendromudur. Ayrıca başta astım, malinite ve interstisyel akciğer hastalıklarıolmak üzere pek çok akciğer hastalığına eozinofili eşlik eder.Bu yazıda primer eozinofilik akciğer hastalıkları gözden geçirilmiştir.

🔖

Cite This Article

MÜDERRİSOĞLU, A. C., ERDENEN, F. (2022). Eosinophilic Pulmonary Diseases in Adults. İstanbul Medical Journal, Cilt: 19 - Sayı: 3, 189–193. https://ajindex.com/articles/552035

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Meeker DP. Pulmonary infiltrates and eosinophilia revisited. Cleve Clin J Med 1989
  2. [CrossRef] 2. DeBrosso CW, Rothenberg ME. Eosinophilia: clinical manifestations and therapeutic options. Allergy 2012
  3. Rose DM, Hrncir DE. Primary eosinophilic lung diseases. Allergy Asthma Proc 2013
  4. [CrossRef] 4. George L, Brightling CE. Eosinophilic airway inflammation: role in asthma and chronic obstructive pulmonary disease Ther Adv Chronic Dis 2016
  5. [CrossRef] 5. Gómez Torrijos E, Mur Gimeno P, Martín Iglesias A, García Rodriguez R, Galindo Bonilla P, El Kaddioui S, et al. Eosinophilic Bronchitis and Idiopathic Eosinophilic Esophagitis. J Investig Allergol Clin Immunol 2016
  6. [CrossRef] 6. Ryan F. Eosinophilic lung diseasee: a clinical overwiew. The Canadian Journal of CME 2001
  7. Rochester CL. The eosinophilic pneumonias. In: Grippi MA, Elias JA, Fishman JA, Kotloff RM, Pack AI, Senior RM, et al., editors. Fishman’s Pulmonary Diseases and Disorders. New York
  8. McGraw Hill Medical: 2015.p.1037-61. 8. Klion AD, Weller PF. Causes of pulmonary eosinophilia. Available from: URL: http:/www.uptodate.com© 2017UpToDate® 9. Campos LEM, Pereirra LFF. Pulmonary eosinophilia. J Bras Pneumol 2009
  9. [CrossRef] 10. Lobo A, Dweik RA. A 57 year- old woman with pulmonary infiltrates and eosinophilia. Clev Clin J Med 1999
  10. [CrossRef] 11. Özkan M, Dweik RA, Ahmad M. Drug-induced lung disease. Cleve Clin J Med 2001
  11. [CrossRef] 12. Cain HC. Drug-induced lung disease due to nonchemotherapeutic agents. In: Grippi MA, Elias JA, Fishman JA, Kotloff RM, Pack AI, Senior RM, et al., editors. Fishman’s Pulmonary Diseases and Disorders. New York
  12. McGraw Hill Medical: 2015.p.1086-102. 13. Weissler JC. Eosinophilic Lung Disease. Am J Med Sci 2017
  13. [CrossRef] 14. King TE, Flaherty KR, Hollingsworth H. Idiopathic acute eosinophilic pneumonia. Available from: URL: http:/www.uptodate.com© 2017UpToDate® 15. Cottin V. Eosinophilic Lung Diseases. Clin Chest Med 2016
  14. [CrossRef] 16. Sriratanaviriyakul N, La HH, Albertson TE. Chronic eosinophilic pneumonia presenting with ipsilateral pleural effusion: a case report. J Med Case Rep 2016
  15. [CrossRef] 17. Roufosse F, Bochner BS, Feldweg AM. Clinical manifestations, patholophysiology, and diagnosis of the hypereosinophilic syndrome. Available from: URL: http:/www.uptodate.com© 2013UpToDate® 18. Chupp G, Rochester CL. Allergic br